Patents by Inventor Keith Mills

Keith Mills has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11321540
    Abstract: Fragment recall and adaptive automated translation are disclosed herein. An example method includes determining that an exact or fuzzy match for a portion of a source input cannot be found in a translation memory, performing fragment recall by matching subsegments in the portion against one or more whole translation units stored in the translation memory, and matching subsegments in the portion against corresponding one or more subsegments inside the one or more matching whole translation units, and returning any of the one or more matching whole translation units and the one or more matching subsegments as a fuzzy match, as well as the translations of those subsegments.
    Type: Grant
    Filed: February 4, 2020
    Date of Patent: May 3, 2022
    Assignee: SDL Inc.
    Inventors: Erik de Vrieze, Keith Mills
  • Publication number: 20200175234
    Abstract: Fragment recall and adaptive automated translation are disclosed herein. An example method includes determining that an exact or fuzzy match for a portion of a source input cannot be found in a translation memory, performing fragment recall by matching subsegments in the portion against one or more whole translation units stored in the translation memory, and matching subsegments in the portion against corresponding one or more subsegments inside the one or more matching whole translation units, and returning any of the one or more matching whole translation units and the one or more matching subsegments as a fuzzy match, as well as the translations of those subsegments.
    Type: Application
    Filed: February 4, 2020
    Publication date: June 4, 2020
    Inventors: Erik de Vrieze, Keith Mills
  • Patent number: 10635863
    Abstract: Fragment recall and adaptive automated translation are disclosed herein. An example method includes determining that an exact or fuzzy match for a portion of a source input cannot be found in a translation memory, performing fragment recall by matching subsegments in the portion against one or more whole translation units stored in the translation memory, and matching subsegments in the portion against corresponding one or more subsegments inside the one or more matching whole translation units, and returning any of the one or more matching whole translation units and the one or more matching subsegments as a fuzzy match, as well as the translations of those subsegments.
    Type: Grant
    Filed: October 30, 2017
    Date of Patent: April 28, 2020
    Assignee: SDL Inc.
    Inventors: Erik de Vrieze, Keith Mills
  • Patent number: 10493071
    Abstract: There is provided the use of compounds of formula I wherein R1, R2, R3 and X have meanings given in the description, for the preparation of a medicament for killing clinically latent microorganisms. There is also provided the use of compounds of formula I for treating microbial infections, as well as certain compounds of formula I per se.
    Type: Grant
    Filed: May 30, 2017
    Date of Patent: December 3, 2019
    Assignee: HELPERBY THERAPEUTICS LIMITED
    Inventors: Petra Helga Beck, Marc Barry Brown, David Edward Clark, Anthony Coates, Hazel Joan Dyke, Yanmin Hu, Derek John Londesbrough, Keith Mills, Thomas David Pallin, Gary Patrick Reid, Gerlinda Stoddart
  • Publication number: 20190129946
    Abstract: Fragment recall and adaptive automated translation are disclosed herein. An example method includes determining that an exact or fuzzy match for a portion of a source input cannot be found in a translation memory, performing fragment recall by matching subsegments in the portion against one or more whole translation units stored in the translation memory, and matching subsegments in the portion against corresponding one or more subsegments inside the one or more matching whole translation units, and returning any of the one or more matching whole translation units and the one or more matching subsegments as a fuzzy match, as well as the translations of those subsegments.
    Type: Application
    Filed: October 30, 2017
    Publication date: May 2, 2019
    Inventors: Erik de Vrieze, Keith Mills
  • Publication number: 20170258784
    Abstract: There is provided the use of compounds of formula I wherein R1, R2, R3 and X have meanings given in the description, for the preparation of a medicament for killing clinically latent microorganisms. There is also provided the use of compounds of formula I for treating microbial infections, as well as certain compounds of formula I per se.
    Type: Application
    Filed: May 30, 2017
    Publication date: September 14, 2017
    Applicant: HELPERBY THERAPEUTICS LIMITED
    Inventors: Petra Helga BECK, Marc Barry BROWN, David Edward CLARK, Anthony COATES, Hazel Joan DYKE, Yanmin HU, Derek John LONDESBROUGH, Keith MILLS, Thomas David PALLIN, Gary Patrick REID, Gerlinda STODDART
  • Patent number: 9694006
    Abstract: There is provided the use of compounds of formula I wherein R1, R2, R3 and X have meanings given in the description, for the preparation of a medicament for killing clinically latent microorganisms. There is also provided the use of compounds of formula I for treating microbial infections, as well as certain compounds of formula I per se.
    Type: Grant
    Filed: May 17, 2012
    Date of Patent: July 4, 2017
    Assignee: HELPERBY THERAPEUTICS LIMITED
    Inventors: Petra Helga Beck, Marc Barry Brown, David Edward Clark, Anthony Coates, Hazel Joan Dyke, Yanmin Hu, Derek John Londesbrough, Keith Mills, Thomas David Pallin, Gary Patrick Reid, Gerlinda Stoddart
  • Patent number: 9400786
    Abstract: A computer-implemented method for use in natural language translation comprises performing in software processes, the steps of: comparing source material with stored material in a first natural language, said stored material having previously been translated from said first natural language to at least a second natural language, identifying at least a part of said source material which has a relationship with at least a part of said stored material, outputting said identified part of source material and said identified part of stored material in a form suitable for review by a user, and replacing said identified part of source material with said identified part of stored material to assist full translation of said source material from said first natural language to at least said second natural language.
    Type: Grant
    Filed: July 25, 2013
    Date of Patent: July 26, 2016
    Assignee: SDL PLC
    Inventors: Mark Lancaster, Alastair Gordon, Keith Mills
  • Publication number: 20140012565
    Abstract: A computer-implemented method for use in natural language translation, including, performing in software processes, the steps of: comparing source material with stored material in a first natural language, said stored material having previously been translated from said first natural language to at least a second natural language, identifying at least a ‘part of said source material which has a relationship with at least a part of said stored material, outputting said identified part of source material and said identified part of stored material in a form suitable for review by a user, and replacing said identified part of source material with said identified part of stored material to assist full translation of said source material from said first natural language to at least said second natural language.
    Type: Application
    Filed: September 5, 2013
    Publication date: January 9, 2014
    Applicant: SDL Language Technologies
    Inventors: Mark Lancaster, Alistair Gordon, Keith Mills
  • Publication number: 20130346062
    Abstract: A computer-implemented method for use in natural language translation comprises performing in software processes, the steps of: comparing source material with stored material in a first natural language, said stored material having previously been translated from said first natural language to at least a second natural language, identifying at least a part of said source material which has a relationship with at least a part of said stored material, outputting said identified part of source material and said identified part of stored material in a form suitable for review by a user, and replacing said identified part of source material with said identified part of stored material to assist full translation of said source material from said first natural language to at least said second natural language.
    Type: Application
    Filed: July 25, 2013
    Publication date: December 26, 2013
    Inventors: Mark Lancaster, Alistair Gordon, Keith Mills
  • Patent number: 8521506
    Abstract: A computer-implemented method for use in natural language translation comprises performing in software processes, the steps of: comparing source material with stored material in a first natural language, said stored material having previously been translated from said first natural language to at least a second natural language, identifying at least a part of said source material which has a relationship with at least a part of said stored material, outputting said identified part of source material and said identified part of stored material in a form suitable for review by a user, and replacing said identified part of source material with said identified part of stored material to assist full translation of said source material from said first natural language to at least said second natural language.
    Type: Grant
    Filed: September 21, 2006
    Date of Patent: August 27, 2013
    Assignee: SDL PLC
    Inventors: Mark Lancaster, Alastair Gordon, Keith Mills
  • Publication number: 20120231995
    Abstract: There is provided the use of compounds of formula I wherein R1, R2, R3 and X have meanings given in the description, for the preparation of a medicament for killing clinically latent microorganisms. There is also provided the use of compounds of formula I for treating microbial infections, as well as certain compounds of formula I per se.
    Type: Application
    Filed: May 17, 2012
    Publication date: September 13, 2012
    Applicant: HELPERBY THERAPEUTICS LIMITED
    Inventors: Petra Helga Beck, Marc Barry Brown, David Edward Clark, Anthony Coates, Hazel Joan Dyke, Yanmin Hu, Derek John Londesbrough, Keith Mills, Thomas David Pallin, Gary Patrick Reid, Gerlinda Stoddart
  • Patent number: 8207187
    Abstract: There is provided the use of compounds of formula I wherein R1, R2, R3 and X have meanings given in the description, for the preparation of a medicament for killing clinically latent microorganisms. There is also provided the use of compounds of formula I for treating microbial infections, as well as certain compounds of formula I per se.
    Type: Grant
    Filed: November 8, 2006
    Date of Patent: June 26, 2012
    Assignee: Helperby Therapeutics Limited
    Inventors: Petra Helga Beck, Marc Barry Brown, David Edward Clark, Anthony Coates, Hazel Joan Dyke, Yanmin Hu, Derek John Londesbrough, Keith Mills, Thomas David Pallin, Gary Patrick Reid, Gerlinda Stoddart
  • Publication number: 20090137622
    Abstract: There is provided the use of compounds of formula I wherein R1, R2, R3 and X have meanings given in the description, for the preparation of a medicament for killing clinically latent microorganisms. There is also provided the use of compounds of formula I for treating microbial infections, as well as certain compounds of formula I per se.
    Type: Application
    Filed: November 8, 2006
    Publication date: May 28, 2009
    Applicant: HELPERBY THERAPEUTICS LIMITED
    Inventors: Petra Helga Beck, Marc Barry Brown, David Edward Clark, Anthony Coates, Hazel Joan Dyke, Yanmin Hu, Derek John Londesbrough, Keith Mills, Thomas David Pallin, Gary Patrick Reid, Gerlinda Stoddart
  • Publication number: 20080077395
    Abstract: A computer-implemented method for use in natural language translation comprises performing in software processes, the steps of: comparing source material with stored material in a first natural language, said stored material having previously been translated from said first natural language to at least a second natural language, identifying at least a part of said source material which has a relationship with at least a part of said stored material, outputting said identified part of source material and said identified part of stored material in a form suitable for review by a user, and replacing said identified part of source material with said identified part of stored material to assist full translation of said source material from said first natural language to at least said second natural language.
    Type: Application
    Filed: September 21, 2006
    Publication date: March 27, 2008
    Applicant: SDL plc
    Inventors: Mark Lancaster, Alastair Gordon, Keith Mills
  • Publication number: 20080045596
    Abstract: A compound selected from one of the following: or a salt, solvate, chemically protected form or prodrug thereof, and its use in treating conditions alleviated by agonism of an EP2 receptor.
    Type: Application
    Filed: December 22, 2004
    Publication date: February 21, 2008
    Inventors: Richard Anthony Borman, Robert Alexander Coleman, Kenneth Lyle Clark, Keith Mills, Alexander William Oxford, Jian Zhang, Peter Thomas Duff
  • Publication number: 20070233460
    Abstract: A computer-implemented method for use in natural language translation. The method involves attaching pieces of linguistic information to two or more source language elements in a source material in a first natural language. The pieces of linguistic information are matched to one or more predetermined parse rules. Associations are then formed between the two or more source language elements to form terminology candidates, which are then presented to human reviewers. Terminology candidates are subsequently validated by a user, becoming validated terminology which is then translated into a second, different, natural language, becoming translated terminology. The translated terminology can then be loaded into a machine-translation dictionary which can be used during subsequent machine-assisted translations.
    Type: Application
    Filed: August 11, 2005
    Publication date: October 4, 2007
    Applicant: SDL plc
    Inventors: Mark Lancaster, James Marciano, Keith Mills
  • Publication number: 20050209336
    Abstract: A compound selected from one of the following: or a salt, solvate, chemically protected form or prodrug thereof, and its use in treating conditions alleviated by agonism of an EP2 receptor.
    Type: Application
    Filed: December 22, 2004
    Publication date: September 22, 2005
    Inventors: Richard Borman, Robert Coleman, Kenneth Clark, Keith Mills, Alexander Oxford, Jian Zhang, Peter Duff
  • Patent number: 5196534
    Abstract: The invention relates to a process for the preparation of a compound of formula (I) ##STR1## wherein R represent a hydrogen atom or a methyl or ethyl group, which comprises cyclising a compound of formul (IV) ##STR2## Where R represents a hydrogen atom, the compound of formula (IV) may optionally be alkylated to produce a compound in whcich R is methyl or ethyl.The compound of formula (I) is useful as an intermediate in the preparation of 2,3,4,5-tetrahydro-2-[(imidazol-4(or 5)-yl)methyl]-1H-pyrido[4,3-b]indol-1-ones having 5-HT.sub.3 antagonist activity.
    Type: Grant
    Filed: May 22, 1991
    Date of Patent: March 23, 1993
    Assignee: Glaxo Group Limited
    Inventors: John W. F. Whitehead, Keith Mills, Ian H. Coates, Alexander W. Oxford, Peter C. North
  • Patent number: 5039673
    Abstract: Compounds are described of the formula (1) ##STR1## where: R.sup.1 is a hydrogen atom or a methyl group;X is cis or trans --CH.dbd.CH-- or --CH.sub.2 CH.sub.2 --, m is 2, 3 or 4 and n is 1; or X is trans --CH.dbd.CH--, m is zero and n is 3;Y is a saturated heterocyclic amino group;Alk is a C.sub.1-5 alkyl chain;l is zero or 1;p is zero, 1, 2, 3 or 4;R.sup.2 is a hydroxyl group or a group selected from --OCOR.sup.3, --CO.sub.2 R.sup.3, CONR.sup.3 R.sup.4, --SO.sub.2 NR.sup.3 R.sup.4, --NHCOR.sup.3, --NHSO.sub.2 R.sup.5, --SO.sub.2 R.sup.5, --SR.sup.5, --NR.sup.3 R.sup.4, --COR.sup.5, --NHCONR.sup.3 R.sup.4 and --NHCSNH.sub.2 ; and their physiologically acceptable salts, solvates and cyclodextrin complexes.These compounds inhibit blood platelet aggregation, bronchoconstriction and vasoconstriction and may be formulated for use as antithrombotic agents.
    Type: Grant
    Filed: August 22, 1989
    Date of Patent: August 13, 1991
    Assignee: Glaxo Group Limited
    Inventors: Eric W. Collington, Harry Finch, Roger Hayes, Keith Mills, David F. Woodings